OKX survey shows Gen Z trusts crypto far more than Baby Boomers which highlights a growing generational shift toward decentralized finance (DeFi) adoption.OKX survey shows Gen Z trusts crypto far more than Baby Boomers which highlights a growing generational shift toward decentralized finance (DeFi) adoption.

Gen Z Adopting Crypto Faster than Baby Boomers, OKX Survey Findings

okx96749

A Survey conducted by a new OKX team of 1000 Americans in January 2026, which gives amazing outcomes in comparison between two different time periods’ generation about the use of crypto and traditional money saving in banks. The purpose is to figure out the acceptance of cryptocurrency in this modern world among younger and older generations.

The survey explains the acceptance of crypto in a clear way by showing a huge difference between Gen Z and Baby Boomers. Basically, Baby Boomers belong to the time period of the 19th century, and they have a mentality level in accordance with that era. So, at that time Banks were believed as secure place for saving assets due to being under the custody of a centralized setup. While Gen Z knows the digital world better and knows decentralization.

Gen Z and Millennials Show Higher Trust in Crypto Than Baby Boomers

The results of this survey show that 40% of Gen Z and 41% of Millennials got high scores above 7+, ranging from 1-10 on a trust scale than to only 9% of Baby Boomers. By calculating, it is understood that Younger generations are 5x more trusting than their older generation. The only reason behind this is that there is a trust level inculcated in their minds that only banks are a secure place for every asset.

OKX Report Stats

In this, 74% of Boomers gave a huge amount of votes toward the legacy of institutions, or approximately 8x more than they give to crypto. On the opposite side, approximately one of five Gen Z (22%) and Millennials (21) Millennials show low trust in banks, indicating a wider doubt toward the traditional system among younger users.

The Generational Trust Gap Is Fueling, Not Hindering, Crypto Adoption

There is also still a significant figure of 71% people showing that they believe in banks as a convincing source of the financial system for years to come. In contrast, more than half of Gen Z (52%) and Millennials (50%) are in favor of crypto in the future as a dominant force. The statistical data of (Jan 2025 v. Jan 2026) reveals the upward trajectory in trust perspective toward crypto platforms has increased over the recent years; these data shows 36% of Gen Z and 34% of Millennials are included in this category.

Trust Gap

Furthermore, the momentum resumes 40% of Gen Z and 36% of Millennials plan to increase their investments in trading in 2026. This is going to make younger traders nearly 4x more bullish than boomers, with 11%.  For Gen Z, Millennials, and even Gen X, platform security remains at the top of the list, cited by 59%, 50%, and 54%, respectively. However, Boomers prioritize regulation and legal safety above all else, with 65% naming it their top concern. In short, the generational trust gap is not a hindrance; rather, it is crypto growth with the passage of time.

Market Opportunity
Babylon Logo
Babylon Price(BABY)
$0.01717
$0.01717$0.01717
+0.52%
USD
Babylon (BABY) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Trump Filed a Lawsuit Against JPMorgan Chase And Its CEO Over Debanking

Trump Filed a Lawsuit Against JPMorgan Chase And Its CEO Over Debanking

U.S. President Donald Trump filed a lawsuit against JPMorgan Chase and its CEO Jamie Dimon personally, accusing the institution of deliberate debanking. The politician
Share
Incrypted2026/01/23 15:59
Here’s why Polygon price is at risk of a 25% plunge

Here’s why Polygon price is at risk of a 25% plunge

Polygon price continued its freefall, reaching its lowest level since April 21, as the broader crypto sell-off gained momentum. Polygon (POL) dropped to $0.1915, down 32% from its highest point in May and 74% below its 2024 peak. The crash…
Share
Crypto.news2025/06/19 00:56
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26